Leaflet DRIPTANE 5mg tablets

Indicated for: overactive bladder; urinary incontinence

Route of administration: oral

Substance: oxybutynin (urinary antimuscarinic)

ATC: G04BD04 (Genito urinary system and sex hormones | Urologicals | Drugs for urinary frequency and incontinence)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Oxybutynin is a medication used to treat overactive bladder and other urinary disorders associated with detrusor instability. It belongs to the class of anticholinergics and works by relaxing the bladder muscles, thereby reducing involuntary contractions and the frequency of urinary urgency.

It is indicated for relieving symptoms such as frequent urination, urinary incontinence, and the urgent need to urinate. Oxybutynin is available in tablet form, transdermal patches, or oral solutions, with the dosage adjusted based on the patient's needs.

Common side effects include dry mouth, constipation, drowsiness, dizziness, and blurred vision. In rare cases, confusion or allergic reactions may occur. It is important to take oxybutynin as prescribed by a healthcare provider, and patients with glaucoma, gastrointestinal obstructions, or other conditions should inform their doctor before use.

DRIPTANE 5mg tablets MYLAN, oxybutynin

General data about DRIPTANE 5mg

  • Substance: oxybutynin
  • Date of latest medicines list: 01-06-2026
  • Product code: W62337001
  • Concentration: 5mg
  • Pharmaceutical form: tablets
  • Quantity: 60
  • Product type: Generic medicine
  • Price: 28.02 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: RECIPHARM FONTAINE - FRANTA
  • Holder: MYLAN MEDICAL S.A.S. - FRANTA
  • Number: 9945/2017/01
  • Shelf life: 3 years

Pharmaceutical forms available for oxybutynin

Concentrations available for oxybutynin

  • 3.9mg/24h
  • 5mg

Compensation lists for DRIPTANE 5mg Mylan

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

28.02 RON

8.66 RON

19.36 RON